MyFinsight
Home
Blog
About
Contact
Download
Download image
Income (loss) from
discontinued operations, net...
$24,715K
Net loss
$2,729K
Loss from continuing
operations, net of tax
-$21,986K
Other income
(expense), net
$11,068K
Interest income
$2,592K
Comprehensive loss
$2,594K
Foreign currency
translation (loss) gain
-$243K
Income tax provision on
continuing operations
$921K
Loss from continuing
operations before income...
-$21,065K
Total other income,
net
$11,366K
Interest expense
$2,294K
Operating loss
-$32,431K
Total
revenue-Product
$125,212K
Total
revenue-License
$4,476K
Total operating
expenses
$162,119K
Cost of goods sold
$2,554K
Selling, general and
administrative
$101,695K
Research and development
$57,870K
License
$928K
Product
$1,626K
Back
Back
Income Statement
source: myfinsight.com
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)